A randomised controlled clinical trial to evaluate the anti-osteolytic agent clodronate for the prevention of the development of bone metastases in patients with primary breast cancer

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2006
This article has no abstract
Epistemonikos ID: 4d276963da60df3699cbd11b6f8455dec3db5d72
First added on: Jan 17, 2025